Treating human disease at the genetic level, by replacing defective genes or adding new genes to enhance native functions, has been a long-standing goal, with the first attempts at gene editing dating back to the 1980s1. However, it wasn’t until 2012 that momentum in the field surged, thanks to the discovery of the CRISPR/Cas9 genome […]